Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Fox Allan M., Director. Officer active across 1 company, notably REGENXBIO Inc.. Aggregated, 6 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €3.7m. Activity tracked since 17 September 2021. The latest transaction was disclosed on 30 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Allan M. Fox serves as a Director at REGENXBIO Inc. In this role, he participates in the governance of the company and strategic decision-making. Allan brings significant experience in the biopharmaceutical sector, enabling him to contribute to discussions on the direction and performance of the company. His expertise helps REGENXBIO achieve its growth objectives.